Taylor Schreiber
CIK: 0001601942
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Shattuck Labs, Inc.
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- May 12, 2026STTK
Shattuck Labs, Inc.
Award(A)Direct25.6K shares at avg. $1.08$28K - May 12, 2026STTK
Shattuck Labs, Inc.
Exercise(M)DirectWarrants (Right to Buy)
25.6K shares- - Jan 10, 2026STTK
Shattuck Labs, Inc.
Award(A)DirectStock Option (Right to Buy)
1.5M shares- - Aug 25, 2025STTK
Shattuck Labs, Inc.
Award(A)Direct25.6K shares at avg. $0.87$22K - Jan 28, 2025STTK
Shattuck Labs, Inc.
Award(A)DirectStock Option (Right to Buy)
684.6K shares- - Oct 7, 2024STTK
Shattuck Labs, Inc.
Purchase(P)Direct36.5K shares at avg. $1.21$44K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 12, 2026 | STTK Shattuck Labs, Inc. | Award(A) | 25,610 | $1.08 | $27,777 | Direct |
| May 12, 2026 | STTK Shattuck Labs, Inc. | Exercise(M) Warrants (Right to Buy) | 25,610 | - | - | Direct |
| Jan 10, 2026 | STTK Shattuck Labs, Inc. | Award(A) Stock Option (Right to Buy) | 1,548,300 | - | - | Direct |
| Aug 25, 2025 | STTK Shattuck Labs, Inc. | Award(A) | 25,610 | $0.87 | $22,222 | Direct |
| Jan 28, 2025 | STTK Shattuck Labs, Inc. | Award(A) Stock Option (Right to Buy) | 684,600 | - | - | Direct |
| Oct 7, 2024 | STTK Shattuck Labs, Inc. | Purchase(P) | 36,500 | $1.21 | $44,220 | Direct |
1-6 of 6 transactions
About Schreiber Taylor
Schreiber Taylor (SEC CIK 0001601942) files insider reports with the SEC as Chief Executive Officer of Shattuck Labs, Inc. (STTK).
Signal8 holds 5 ownership filings by Schreiber Taylor, all Form 4s, filed between Oct 8, 2024 and May 13, 2026. Those filings report 6 transactions, from Oct 7, 2024 to May 12, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Schreiber Taylor's filings is in AUSTIN, TX.
Recent filings by Schreiber Taylor
- May 12, 2026: Grant or award of STTK shares (Form 4, code A).
- May 12, 2026: Option exercise of STTK derivative securities (Form 4, code M).
- Jan 10, 2026: Grant or award of STTK derivative securities (Form 4, code A).
- Aug 25, 2025: Grant or award of STTK shares (Form 4, code A).
- Jan 28, 2025: Grant or award of STTK derivative securities (Form 4, code A).
Other insiders filing for Shattuck Labs, Inc. (STTK)
- Shukla Abhinav A., Chief Technical Officer
- Pandite Arundathy N., Chief Medical Officer
- Ashiya Mona, Director
- ORBIMED ADVISORS LLC, Director
- SIEGALL CLAY B, Director
- Baker Daniel G., Director